• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.17% Nasdaq Up 1.27%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    8.85 Up 0.32(3.75%) Apr 20, 4:00PM EDT
    Add to Portfolio
    Prev Close:8.53
    Open:8.90
    Bid:N/A
    Ask:9.75 x 100
    1y Target Est:9.00
    Beta:-0.33
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:8.50 - 9.02
    52wk Range:2.97 - 9.18
    Volume:1,228,936
    Avg Vol (3m):334,610
    Market Cap:213.49M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TROV

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):734.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.92
    Quarterly EPS Est (Mar-15) :-0.23
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback